Bioscience-Medicine · Texas Biomed withdraws $11 million bond request from the city of San Antonio amid PETA complaints. Stay Connected.
News
- Omicron is now the dominant COVID strain in the U.S., making up 73% of new infections | TPR
- LA Clippers star Paul George returns from elbow injury vs. San Antonio Spurs - ABC7 Los Angeles
LA Clippers star Paul George returns Monday against the Spurs after missing five games with a right elbow sprain.
- StemBioSys expanding product portfolio and talent pipeline - San Antonio Business Journal
San Antonio-based StemBioSys Inc. is expanding its product portfolio and ... SA biotech company's first cancer test ready to hit the market INNO.
- San Antonio Food Bank CEO on the state of local food insecurity and expanded efforts to ...
The level of food insecurity in San Antonio has waned from its worst point during the pandemic, but demand is still considerable as area residents ...
- Ball, Occidental fall; Verso, Bluerock Residential rise - San Antonio Express-News
The biotechnology company put a partial hold on a program to develop a sickle cell disease treatment. Cerner Inc., up 72 cents to $90.49.